Back to search

University of Edinburgh

Defining the therapeutic potential of regulatory T cells in promoting bile duct regeneration

Abstract

dc:description.abstract

The liver is unique in its ability to fully regenerate following partial hepatectomy or acute injury through complex regenerative mechanisms that involve interactions between various cell types. Nonetheless, these mechanisms are compromised during chronic or repeated injuries. Primary sclerosing cholangitis (PSC) is a rare biliary disease characterized by the inflammation and fibrosis of intra- and extrahepatic bile ducts, leading to obstructed bile flow and liver damage. Although its aetiology remains unknown, it is thought to be immune-mediated. PSC patients display reduced numbers of peripheral Foxp3+ regulatory T cells (Tregs) compared to healthy individuals and those with primary biliary cholangitis (PBC), together with impaired suppressive function. This suggests that Treg dysfunction may contribute to PSC pathogenesis. This thesis explores the role and therapeutic potential of Tregs in biliary injury using mouse models of biliary injury, with four key chapters: Chapter 3 explores the role of Tregs in biliary injury, showing that livers from PSC patients have limited infiltration of Foxp3+ Tregs. The reduction of Tregs in a biliary injury mouse model worsens liver damage and hinders biliary regeneration, emphasising the significance of Tregs in this process. Chapter 4 assesses the therapeutic potential of Tregs-based immunotherapy. It shows that low-dose IL-2 antibody complex (IL-2c) injection expands intrahepatic Tregs in injured livers. However, these expanded Tregs lose Foxp3 expression and acquire a pro-inflammatory phenotype, known as ExTregs. This leads to worsened liver injury and reduced biliary regeneration, revealing the importance of maintaining Treg stability in Tregs-based immunotherapy. Chapter 5 aims to enhance the efficacy of IL-2c-mediated immunotherapy by stabilising Tregs through OX40 signalling inhibition. Blocking the OX40 ligand (Ox40L) after IL-2c treatment reduces ExTreg generation and promotes the expansion of stable Tregs. This improves the regenerative ductular reaction and reduces fibrosis and cholangiocyte senescence in a murine cholangitis model, suggesting a potential therapeutic improvement in Tregs-based immunotherapy. Chapter 6 investigates how Tregs promote biliary regeneration, focusing on the role of amphiregulin (Areg), a mitogen secreted by Tregs. Areg promotes biliary proliferation and reduces liver fibrosis in Areg-treated cholangitis mice. Intrahepatic Tregs are identified as a major source of Areg, and Treg-specific Areg depletion impairs biliary regeneration while reducing liver fibrosis. In conclusion, this thesis highlights the critical role of Tregs in biliary regeneration and injury resolution. It proposes potential Tregs-mediated immunotherapy for PSC and identifies Areg as a key factor in Treg-mediated biliary repair.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wong, Man Chun
Advisors dc:contributor.advisor
  • Lu, Wei-Yu
  • Rossi, Adriano
  • Ramachandran, Prakash

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Wong, Man Chun. Defining the therapeutic potential of regulatory T cells in promoting bile duct regeneration. 2025. https://era.ed.ac.uk/handle/1842/44463